Rimantadine Hydrochloride (Impax Generics)
Welcome to the PulseAid listing for the Rimantadine Hydrochloride drug offered from Impax Generics. This Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Impax Generics |
NON-PROPRIETARY NAME: | Rimantadine Hydrochloride |
SUBSTANCE NAME: | RIMANTADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-04-01 |
END MARKETING DATE: | 0000-00-00 |
Rimantadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Rimantadine Hydrochloride from Impax Generics |
LABELER NAME: | Impax Generics |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2005-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0115-1911_cbee6148-5b85-4baa-8764-be925110f459 |
PRODUCT NDC: | 0115-1911 |
APPLICATION NUMBER: | ANDA076132 |
Other RIMANTADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: